Loading chart…
PRE-MARKET
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline.
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The AAREYDRUGS share price is ₹109.04 (+1.23% today), with a market capitalisation of ₹3B and a price-to-earnings (P/E) ratio of 74.2. MarketRipple tracks the AAREYDRUGS investment thesis, the ripple-chain impact of market events on Aarey Drugs & Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹110.00
High
₹110.00
Low
₹106.69
Prev. Close
₹107.72
52W High
₹114.80
52W Low
₹50.31
Day range
₹106.69–₹110.00
52-week range
₹50.31–₹114.80
Volume
252K
P/E
74.2
ROE
2.6%
D/E
0.33
Margin
0.9%
Aarey Drugs & Pharmaceuticals Limited (NSE: AAREYDRUGS) is currently trading at ₹109.04 (+1.23%).
Aarey Drugs & Pharmaceuticals Limited's market capitalization is ₹3B.
Aarey Drugs & Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 74.2.
Aarey Drugs & Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).